Overview

The GMO Emerging Markets Series Fund seeks total return in excess of that of its benchmark, the MSCI Emerging Markets Index. GMO uses proprietary quantitative techniques and fundamental analysis to evaluate and select countries, sectors, and equity investments based on factors including, but not limited to, valuation, quality, patterns of price movement and volatility, macroeconomic factors, and ESG (environmental, social and governance) criteria. GMO expects the Strategy will have a value bias relative to its benchmark.

Facts

Doc Table
Fund Inception Date May 2, 2014
Fund Total Assets as of 8/31/2020 $34mm USD
Benchmark MSCI Emerging Markets

Share Class R6

Inception Date May 2, 2014
Ticker Symbol GECRX
CUSIP 380131656
NAV as of 9/18/2020 9.55
Net Expense Ratio 1 0.94
Gross Expense Ratio 2 1.03

1 Net Expense Ratio reflects the reduction of expenses from fee reimbursements. The fee reimbursements will continue until at least June 30, 2021. Elimination of this reimbursement will result in higher fees and lower performance.

2 Gross Expense Ratio is equal to the Funds Total Annual Operating Expenses set forth in the Funds most recent prospectus dated June 30, 2020.

Performance

Quarter-End as of June 30, 2020(USD, %) | GMO Emerging Markets Series Fund Class R6

Table Caption
1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Series Fund -5.31 0.92 3.94 2.99 6.73
MSCI Emerging Markets -3.39 1.90 2.86 3.27 5.61
  • Emerging Markets Series Fund
  • MSCI Emerging Markets

Inception Date: August 29, 1997

Returns shown for periods greater than one year are on an annualized basis.

If certain expenses were not reimbursed, performance would be lower. Transaction costs, if any, are paid to the fund to offset the cost of portfolio transactions to invest or raise cash.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Quarter-End as of June 30, 2020(USD, %) | GMO Emerging Markets Series Fund Class R6

Table Caption
QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Series Fund 15.66 -12.18 -5.31 0.92 3.94 2.99 6.73
MSCI Emerging Markets 18.08 -9.78 -3.39 1.90 2.86 3.27 5.61
  • Emerging Markets Series Fund
  • MSCI Emerging Markets

Inception Date: August 29, 1997

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Month-End as of August 31, 2020(USD, %) | GMO Emerging Markets Series Fund Class R6

Table Caption
MTD QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
Emerging Markets Series Fund 0.63 7.05 -5.99 8.26 1.30 8.86 2.85 7.00
MSCI Emerging Markets 2.21 11.34 0.45 14.49 2.83 8.65 3.76 6.06
  • Emerging Markets Series Fund
  • MSCI Emerging Markets

Inception Date: August 29, 1997

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Year Ending December 31 (USD, %) | GMO Emerging Markets Series Fund Class R6

Calendar
Emerging Markets Series Fund MSCI Emerging Markets
2019 21.64 18.44
2018 -12.92 -14.58
2017 32.94 37.28
2016 17.58 11.19
2015 -14.98 -14.92
2014 -6.59 -2.19
2013 -6.62 -2.60
2012 15.02 18.22
2011 -17.21 -18.42
2010 20.40 18.88
  • Emerging Markets Series Fund
  • MSCI Emerging Markets

Inception Date: August 29, 1997

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

Documents

Literature

Fact Sheet - Class PS Download
Fact Sheet - Class R6 Download
Prospectus Download
Summary Prospectus Download
Statement of Additional Information Download
XBRL 485(b) Download
Download All Download

Downloads

Performance Download
Portfolio Composition Download
Holdings Download
Download All Download

Commentary & Attribution

Commentary - Quarterly Download
Attribution - Monthly Download
Attribution - Quarterly Download
Attribution - YTD Download
Download All Download

Investor Information

Annual Report Download
Semiannual Report Download
NAVs and Distributions Download
Distribution Dates Download
Tax-Related Distribution Information Download
Download All Download

Risks

Risks associated with investing in the Fund may include those as follows. (1) Market Risk - Equities: The market price of an equity may decline due to factors affecting the issuer or its industry or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund's shares. (2) Non-U.S. Investment Risk: The market prices of many non-U.S. securities (particularly of companies tied economically to emerging countries) fluctuate more than those of U.S. securities. Many non-U.S. markets (particularly emerging markets), are less stable, smaller, less liquid, and less regulated than U.S. markets, and the cost of trading in those markets often is higher than it is in U.S. markets. These and other risks (e.g., nationalization, expropriation or other confiscation of assets of non-U.S. issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of developed countries. (3) Currency Risk: Fluctuations in exchange rates can adversely affect the market value of the Fund's non-U.S. currency holdings and investments denominated in non-U.S. currencies. For a more complete discussion of these risks and others, please consult the Fund's prospectus.

Disclosures

An investor should consider the fund’s investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund’s prospectus. Read the prospectus carefully before investing. Please see prospectus above. 

Each GMO Series Trust Fund is a feeder fund investing substantially all of its assets in shares of a corresponding GMO Trust Fund (i.e., a master fund). Under the master-feeder structure, each GMO Series Trust Fund's sole portfolio holding, other than cash, is shares of the corresponding GMO Trust Fund.

The GMO Trust funds are distributed in the United States by Funds Distributor LLC. GMO and Funds Distributor LLC are not affiliated.